Russell Investments Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124M Buy
2,895,696
+577,276
+25% +$31.3M 0.11% 181
2026
Q1
$146M Buy
2,318,420
+372,845
+19% +$29.8M 0.16% 126
2025
Q4
$186M Buy
1,945,575
+291,108
+18% +$28.5M 0.2% 84
2025
Q3
$161M Buy
1,654,467
+211,827
+15% +$21.9M 0.18% 100
2025
Q2
$155M Buy
1,442,640
+120,648
+9% +$12.2M 0.2% 90
2025
Q1
$133M Buy
1,321,992
+225,678
+21% +$22.7M 0.18% 110
2024
Q4
$98M Buy
1,096,314
+111,991
+11% +$9.86M 0.14% 150
2024
Q3
$82.4M Buy
984,323
+196,414
+25% +$15.5M 0.12% 184
2024
Q2
$60.7M Buy
787,909
+14,287
+2% +$1.05M 0.1% 214
2024
Q1
$53M Buy
773,622
+31,853
+4% +$2.05M 0.08% 263
2023
Q4
$42.7M Buy
741,769
+122,979
+20% +$6.56M 0.08% 284
2023
Q3
$32.7M Sell
618,790
-57,160
-8% -$3M 0.06% 326
2023
Q2
$36.6M Sell
675,950
-208,229
-24% -$10.9M 0.07% 311
2023
Q1
$44.2M Sell
884,179
-127,508
-13% -$6.01M 0.09% 268
2022
Q4
$46.8M Buy
1,011,687
+58,344
+6% +$2.53M 0.1% 261
2022
Q3
$36.9M Buy
953,343
+508,181
+114% +$20.4M 0.08% 293
2022
Q2
$16.6M Sell
445,162
-235,447
-35% -$9.58M 0.03% 574
2022
Q1
$30.1M Sell
680,609
-24,099
-3% -$1.04M 0.05% 427
2021
Q4
$29.9M Sell
704,708
-211,062
-23% -$8.87M 0.05% 464
2021
Q3
$39.7M Buy
915,770
+502,589
+122% +$22.2M 0.07% 353
2021
Q2
$17.7M Buy
413,181
+12,290
+3% +$517K 0.03% 658
2021
Q1
$15.5M Buy
400,891
+6,761
+2% +$256K 0.03% 700
2020
Q4
$14.1M Sell
394,130
-164,145
-29% -$5.92M 0.03% 664
2020
Q3
$21.3M Sell
558,275
-7,978
-1% -$307K 0.05% 462
2020
Q2
$19.9M Buy
566,253
+82,844
+17% +$2.98M 0.04% 463
2020
Q1
$15.7M Buy
483,409
+65,207
+16% +$2.55M 0.04% 477
2019
Q4
$18.9M Buy
418,202
+12,091
+3% +$506K 0.04% 567
2019
Q3
$16.5M Sell
406,111
-57,432
-12% -$2.43M 0.03% 626
2019
Q2
$19.9M Buy
463,543
+41,420
+10% +$1.59M 0.04% 569
2019
Q1
$16.2M Buy
422,123
+117,022
+38% +$4.47M 0.03% 662
2018
Q4
$10.8M Sell
305,101
-5,852
-2% -$212K 0.02% 767
2018
Q3
$12M Sell
310,953
-14,959
-5% -$522K 0.02% 830
2018
Q2
$10.6M Sell
325,912
-121,607
-27% -$3.67M 0.02% 879
2018
Q1
$12.2M Sell
447,519
-694,478
-61% -$18.9M 0.02% 872
2017
Q4
$28.8M Sell
1,141,997
-122,880
-10% -$3.39M 0.05% 459
2017
Q3
$36.9M Buy
1,264,877
+274,893
+28% +$7.59M 0.06% 370
2017
Q2
$27.4M Buy
989,984
+189,132
+24% +$5.02M 0.05% 474
2017
Q1
$19.9M Sell
800,852
-232,041
-22% -$5.64M 0.04% 571
2016
Q4
$22.4M Buy
+1,032,893
New +$22.5M 0.04% 499

Other funds holding BSX

Russell Investments Group's BSX Position: Q2 2026 in Review

Russell Investments Group increased its Boston Scientific (BSX) stake by 25% in Q2 2026, buying an estimated $31.3M and bringing the position to 2,895,696 shares worth $124M. The position accounts for 0.11% of the portfolio, ranked #181.

Russell Investments Group first reported a position in BSX in Q4 2016 and has held it in 39 quarters since. The position peaked at $186M in Q4 2025. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Russell Investments Group held 2,895,696 shares of Boston Scientific worth $124M as of Q2 2026.
  • Russell Investments Group bought 577,276 Boston Scientific shares in Q2 2026, an estimated $31.3M.
  • Boston Scientific made up 0.11% of Russell Investments Group's portfolio in Q2 2026, its #181 holding.
  • Russell Investments Group first reported a position in Boston Scientific in Q4 2016 and has held it in 39 quarters since.
  • Russell Investments Group's Boston Scientific position peaked at $186M in Q4 2025.
  • 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.